HMT Joins Global Effort to develop Covid-19 Vaccine
HMT is pleased to announce that it has signed a collaborative project agreement with AnGes, Inc. and AnGesand Osaka University for the development of a DNA vaccine against COVID-19
HMT is pleased to announce that it has signed a collaborative project agreement with AnGes, Inc. and AnGesand Osaka University for the development of a DNA vaccine against COVID-19